Skip to main content

Table 1 Baseline characteristics of included patients

From: Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial

Characteristics

AL, n = 340 (%)

ASAQ, n = 340 (%)

P-value

Site

 Nanoro, n (%)

176 (51.76)

176 (51.76)

 Nazoanga, n (%)

164 (48.24)

164 (48.24)

Sex

 Male, n (%)

183 (53.82)

182 (53.53)

0.939

 Female, n (%)

157 (46.18)

158 (46.47)

Age in years, median (p25–p75)

3.26 (1.70–4.98)

3.14 (1.61–5.05)

0.387

Weight in kg, median (p25–p75)

11 (9–14)

10 (9–14)

0.157

Mean temperature (SD)

38.41 (0.91)

38.47 (0.91)

0.381

Hemoglobin in g/dl, median (p25–p75)

9 (8–11)

9 (8–10)

0.019

GMPD (95 % CI)

30,529 (26,809–34,766)

30,763 (27,180–34,818)

0.933